Anebulo Pharmaceuticals, Inc. Competitors
Symbol | Company | Share Price | Market Cap | P/E Ratio | Employee Count | Revenue |
---|---|---|---|---|---|---|
ACRV
|
Acrivon Therapeutics, Inc. Common Stock | $7.80 | $223.86 M | -2.51 | 58 | $0 |
ADAG
|
Adagene Inc. | $3.10 | $131.46 M | -6.77 | 174 | $18.11 M |
ANAB
|
AnaptysBio, Inc. | $19.93 | $640.07 M | -3.82 | 117 | $17.16 M |
ANTX
|
AN2 Therapeutics, Inc. | $1.09 | $60.55 M | -0.81 | 41 | $0 |
AVTE
|
Aerovate Therapeutics, Inc. | $2.71 | $597.48 M | -6.84 | 51 | $0 |
MLYS
|
Mineralys Therapeutics, Inc. | $13.49 | $652.38 M | -6.03 | 28 | $0 |
MOLN
|
Molecular Partners AG | $5.75 | $135.05 M | -2.03 | 167 | $7.04 M |
OPT
|
Opthea Limited | $4.19 | $214.34 M | -1.04 | 33 | $125,122 |
PMVP
|
PMV Pharmaceuticals, Inc. | $1.66 | $85.40 M | -1.26 | 63 | $0 |